PriceTargets.com logo

Advanced Medical Solutions Group - AMS Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 303
  • Forecasted Upside: 24.69%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
GBX 243 As of 06/5/2023 05:42 PM ET
▲ +16.5 (7.28%)

This chart shows the closing price for AMS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Advanced Medical Solutions Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AMS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AMS

Analyst Price Target is GBX 303
▲ +24.69% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Advanced Medical Solutions Group in the last 3 months. The average price target is GBX 303, with a high forecast of GBX 310 and a low forecast of GBX 296. The average price target represents a 24.69% upside from the last price of GBX 243.

This chart shows the closing price for AMS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 polled investment analysts is to buy stock in Advanced Medical Solutions Group.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/12/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/12/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/10/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/8/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/7/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/7/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/6/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/5/2023

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/15/2023Liberum CapitalDowngradeHoldGBX 296
3/15/2023Berenberg BankReiterated RatingBuyGBX 310
1/27/2020Panmure GordonReiterated RatingHold
5/30/2019Numis SecuritiesUpgradeAdd
3/13/2019Numis SecuritiesReiterated RatingAddGBX 340
9/12/2018Numis SecuritiesBoost TargetHoldGBX 275 ➝ GBX 320
(Data available from 6/5/2018 forward)

News Sentiment Rating

1.44 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
11/7/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/7/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/6/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/5/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/7/2023
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/6/2023
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/6/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/5/2023

Current Sentiment

  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

Advanced Medical Solutions Group logo
Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and laparoscopic device used to fix hernia meshes placed inside the body under the LiquiBand Fix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products under the ActivHeal brand. Advanced Medical Solutions Group plc was incorporated in 1991 and is headquartered in Winsford, the United Kingdom.
Read More

Today's Range

Now: GBX 243
Low: 235
High: 246.50

50 Day Range

MA: GBX 236.76
Low: 219.50
High: 253

52 Week Range

Now: GBX 243
Low: 215.50
High: 318.50

Volume

350,396 shs

Average Volume

312,202 shs

Market Capitalization

£527.16 million

P/E Ratio

2,700.00

Dividend Yield

0.90%

Beta

0.6

Frequently Asked Questions

What sell-side analysts currently cover shares of Advanced Medical Solutions Group?

The following equities research analysts have issued reports on Advanced Medical Solutions Group in the last twelve months: Berenberg Bank, and Liberum Capital.
View the latest analyst ratings for AMS.

What is the current price target for Advanced Medical Solutions Group?

2 Wall Street analysts have set twelve-month price targets for Advanced Medical Solutions Group in the last year. Their average twelve-month price target is GBX 303, suggesting a possible upside of 24.7%. Berenberg Bank has the highest price target set, predicting AMS will reach GBX 310 in the next twelve months. Liberum Capital has the lowest price target set, forecasting a price of GBX 296 for Advanced Medical Solutions Group in the next year.
View the latest price targets for AMS.

What is the current consensus analyst rating for Advanced Medical Solutions Group?

Advanced Medical Solutions Group currently has 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AMS will outperform the market and that investors should add to their positions of Advanced Medical Solutions Group.
View the latest ratings for AMS.

What other companies compete with Advanced Medical Solutions Group?

Other companies that are similar to Advanced Medical Solutions Group include Tristel, Consort Medical plc (CSRT.L), Ergomed, Silence Therapeutics and Amryt Pharma. Learn More about companies similar to Advanced Medical Solutions Group.

How do I contact Advanced Medical Solutions Group's investor relations team?

Advanced Medical Solutions Group's physical mailing address is Unit A, Premier Park, 33 Road One, WINSFORD, CW7 3RT, United Kingdom. The company's listed phone number is +44-1606-863500. The official website for Advanced Medical Solutions Group is www.admedsol.com. Learn More about contacing Advanced Medical Solutions Group investor relations.